NovaMedica LLC capital consolidation
Print 20 April 2023
The RMI Group consolidated a 100% stake in the capital of NovaMedica LLC, a Russian specialty pharma company.
The transaction will allow facilitation of efforts on the accelerated development of NovaMedica LLC by bringing the company's own development products to the market (improved generic drugs for the treatment of central nervous system diseases and painkillers), as well as on searching for opportunities to NovaMedica LLC to create strategic partnerships or transactions with leading players in the Russian pharmaceutical market.
All Portfolio
MEDIA CENTER
-
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.